IVG-PREMIUM-E-LIQUIDS
IVG Premium E-Liquids, the UK’s market-leading brand, has announced a strategic partnership with globally renowned Kollaras & Co – A 3rd generation, family owned and operated business. Kollaras & Co specialises in supporting independent retailers across multiple channels in Australia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190325005029/en/
Kollaras & Co have landed the master distribution rights for IVG products within Australia, which will allow vapers from down under to join vapers from over 60 countries and 6 continents that vape premium British flavours from IVG.
John Kollaras, Managing Director of Kollaras & Co, commented that the alliance was an important step for the near 60-year-old business, commenting “We are thrilled to partner with IVG, as we continue to strive to provide a unique offering within our portfolio, and cement our position as a dynamic solutions provider.” Kollaras continued: “Quality, authenticity and passion are three key values which we look for in partners, and IVG is no exception to this.”
Ahsan Bawa, CEO of IVG, commented that “Our incredible journey continues here at IVG, our multi international and award winning brand continues to reach new heights. We are proud and honoured to welcome the Kollaras family into our own, and this strategic alliance will help in those efforts on delivering IVG to a store near you. We are thrilled to officially announce the partnership with Kolloras & Co, a key step for Oceania & South Pacific regions
Kollaras & Co will be distributing 26 delicious e-liquid flavours in 60 ML and 10 ML from IVG Premium E-Liquids’ into the Australia retail market sector by the end of April 2019.
13 International Accolades “Leading E-Liquids Specialist 2019”, Best Sweet Flavour, and more have played a key role in the Australia company taking the products on board, along with the existing reviews of the vape enthusiasts in the Australian market.
Kollaras closed by adding “Our core innovation metrics focus on creating brands that are valued by our customers and deliver outstanding value to their shoppers, and IVG is a fantastic example of this. We are both confident and excited about the partnership and our growth prospects in the year ahead to say the least!”
About IVG Premium E-Liquids - www.ivgeliquids.co.uk
About Kollaras & Co: www.kollaras.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20190325005029/en/
Contact:
Media Contact: Deepika Patel Head of Marketing +44 (0) 1772 217000 deepika.patel@ivgeliquids.com
Social Media:
https://www.facebook.com/ivgeliquids
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KRAFTON Achieves Record-High Quarterly Sales in Q1 202529.4.2025 09:00:00 CEST | Press release
Thanks to PUBG IP expansion, inZOI’s strong debut, and BGMI’s global growth, quarter-over-quarter sales are up 41.6%, while operating profit is up 112.2% KRAFTON, Inc. today announced its first quarter earnings results for 2025. Based on consolidated financial statements prepared in accordance with Korean International Financial Reporting Standards (K-IFRS), the company achieved a record-high quarterly sales performance of 874.2B KRW and operating profit of 457.3B KRW. In addition to high quarter-over-quarter growth, year-over-year growth has also set records with sales up by 31.3% and operating profit upby 47.3%. Significant Growth and Core IP Direction KRAFTON achieved significant growth across all of its business divisions, including PC (323.5B KRW), mobile (532.4B KRW), and console/others (18.3B KRW). On PC platforms, PUBG: BATTLEGROUNDS’ diversified content and strong live-service operations contributed significantly to growth while the successful launch of a new IP, inZOI, also p
Azalea Vision Raises €9 Million in First Closing of Series A to Further Develop Intelligent Connected Vision Platform29.4.2025 09:00:00 CEST | Press release
Industry veteran Robert J. Dempsey Appointed Chairman of the Board to Guide Strategic Growth in Europe and the U.S. Azalea (A-zuh-lay-ah)Vision, a HealthTech company engineering the future of sight, today announced the first closing of its €15 million Series A funding round, raising €9 million along with the appointment of Robert J. Dempsey as Chairman of the Board to guide strategic growth in the European and U.S. markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429247873/en/ Robert Dempsey, Chairman of the Board, Azalea Vision "Strong participation from repeat investors in this Series A milestone reaffirms their trust in our medical device and innovation for the future of intelligent ocular health,” said Enrique Vega, CEO of Azalea Vision. “Additional funding in this round from SPRIM Global Investments and Afrimobility, along with a strategic investor who remains undisclosed, further emphasizes the confidence in
A Third of Global CIOs Warn of Unrealistic Board Expectations as The World Bets Big on AI, According to Expereo29.4.2025 09:00:00 CEST | Press release
A new survey commissioned by Expereo exposes the true roadblocks to global AI plans - poor infrastructure, resistance from employees, unreasonable demands A third of global technology leaders believe their board has unrealistic expectations or demands on how new technologies like AI will impact business performance. This is according to an IDC InfoBrief*, commissioned by Expereo, which highlights serious roadblocks to global AI implementation, despite AI being considered critical to fulfilling business priorities. The research of 650 technology leaders in global organizations across Europe, the US and APAC reveals that 34% of global technology leaders have been forced to reassess their technology infrastructure because of rising geopolitical risks, as 37% say geopolitical disruptions are currently impacting their organization’s growth strategies. Amid the volatile economic backdrop, it seems most organizations are placing their bets on AI to drive growth. The research shows that 87% of
Cyber Guru Named Winner of the Coveted Global InfoSec Awards during RSA Conference 202529.4.2025 09:00:00 CEST | Press release
Cyber Guru Wins Hot Company in Security Awareness Training in the 13th Annual Global InfoSec Awards at #RSAC 2025 Cyber Guru, the leading cybersecurity awareness training platform, is proud to announce we have won the “Hot Company - Security Awareness Training” award from Cyber Defense Magazine (CDM), the industry’s leading electronic information security magazine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250429950821/en/ Cyber Guru, Global InfoSec Award Winner 2025 “We’re thrilled to receive one of the most prestigious and coveted cybersecurity awards in the world from Cyber Defense Magazine, during their 13th anniversary as one of the world’s leading independent cybersecurity news and information provider. We knew the competition would be tough and with top judges who are leading infosec experts from around the globe, we couldn’t be more pleased,” said Gianni Baroni, CEO and founder of Cyber Guru. Cyber Guru embodies
Microba Delivers Landmark IBD Results & Signs Major Gastro Partner29.4.2025 07:52:00 CEST | Press release
Two independent clinical studies have demonstrated that Microba’s MetaPanel™ test identifies gastrointestinal pathogens in >35% of Inflammatory Bowel Disease (IBD) patients experiencing flare, with >60% of these missed by current routine testing methods.These findings have the potential to shift treatment protocols and provide a new path to remission for IBD patients, avoiding unnecessary therapy escalation or surgery.Microba partners with Colonoscopy Clinic and Integrated Gut Health, one of Australia’s largest private gastroenterology services, to embed microbial diagnostic testing into routine care to improve patient outcomes. Microba Life Sciences Limited (ASX: MAP) (“Microba”) a precision microbiome company, today announces two significant developments: the release of new clinical utility results for its MetaPanel™ gastrointestinal pathogen test, and the signing of a strategic clinical partnership with the Colonoscopy Clinic, and its wholly owned partner, Integrated Gut Health, one
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom